In this current study, MM mutational characterisation was performed on ctDNA and paired BM samples from 76 patients utilising the highly sensitive OnTargetTM Mutation Detection (OMD) platform to determine the prognostic significance of ctDNA detectable RAS-RAF and TP53 mutations. The gene discussed is TP53; the disease is Miyoshi myopathy.